Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.
about
Nomograms for prognostic factors of spinal giant cell tumor combining traditional clinical characteristics with inflammatory biomarkers after gross total resection.Blood-based tumor biomarkers in lung cancer for detection and treatment.IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets.TBX21 predicts prognosis of patients and drives cancer stem cell maintenance via the TBX21-IL-4 pathway in lung adenocarcinoma.Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
P2860
Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Identification of serum inflam ...... ty for stage I adenocarcinoma.
@en
type
label
Identification of serum inflam ...... ty for stage I adenocarcinoma.
@en
prefLabel
Identification of serum inflam ...... ty for stage I adenocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
Identification of serum inflam ...... ty for stage I adenocarcinoma.
@en
P2093
Bríd M Ryan
Claire L Meaney
Derek Brown
P2860
P304
40946-40957
P356
10.18632/ONCOTARGET.16784
P407
P577
2017-04-03T00:00:00Z